- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/13 - Tumour cells, irrespective of tissue of origin
Patent holdings for IPC class A61K 35/13
Total number of patents in this class: 322
10-year publication summary
15
|
28
|
33
|
47
|
45
|
41
|
45
|
17
|
19
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Thomas Jefferson University | 526 |
13 |
Iovance Biotherapeutics, Inc. | 317 |
11 |
The Regents of the University of California | 19517 |
6 |
Board of Regents, The University of Texas System | 5619 |
5 |
The Johns Hopkins University | 5533 |
5 |
Trustees of Tufts College | 819 |
5 |
The Board of Trustees of the Leland Stanford Junior University | 6246 |
4 |
Mayo Foundation for Medical Education and Research | 3115 |
4 |
Gradalis, Inc. | 47 |
4 |
Memorial Sloan-Kettering Cancer Center | 1890 |
4 |
Pastoral Greenhouse Gas Research Ltd | 23 |
4 |
Pulse Biosciences, Inc. | 149 |
4 |
SOTIO a.s. | 24 |
4 |
University of Massachusetts | 2191 |
4 |
University of Miami | 830 |
4 |
Imvax, Inc. | 10 |
4 |
Medical Corporation Ichikawa Clinic | 4 |
4 |
UNM Rainforest Innovations | 376 |
4 |
Novartis AG | 11254 |
3 |
President and Fellows of Harvard College | 5913 |
3 |
Other owners | 223 |